UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Wealthquest Corp

Wealthquest Corp grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 470 shares of the healthcare conglomerate’s stock after acquiring an additional 34 shares during the period. Wealthquest Corp’s holdings in UnitedHealth Group were worth $238,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in UNH. EverSource Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 7.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,622 shares of the healthcare conglomerate’s stock valued at $1,335,000 after purchasing an additional 193 shares in the last quarter. Commonwealth Financial Services LLC lifted its position in shares of UnitedHealth Group by 9.0% during the 2nd quarter. Commonwealth Financial Services LLC now owns 726 shares of the healthcare conglomerate’s stock valued at $355,000 after acquiring an additional 60 shares during the period. Public Sector Pension Investment Board grew its holdings in shares of UnitedHealth Group by 26.3% in the 2nd quarter. Public Sector Pension Investment Board now owns 436,747 shares of the healthcare conglomerate’s stock worth $222,418,000 after acquiring an additional 91,022 shares during the period. Magnetar Financial LLC raised its holdings in UnitedHealth Group by 100.7% during the second quarter. Magnetar Financial LLC now owns 159,239 shares of the healthcare conglomerate’s stock worth $81,094,000 after purchasing an additional 79,898 shares during the last quarter. Finally, Evergreen Capital Management LLC grew its holdings in UnitedHealth Group by 7.7% in the second quarter. Evergreen Capital Management LLC now owns 17,644 shares of the healthcare conglomerate’s stock valued at $8,985,000 after purchasing an additional 1,259 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $510.03 on Tuesday. The firm’s fifty day simple moving average is $549.37 and its 200 day simple moving average is $563.70. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The firm has a market capitalization of $469.37 billion, a price-to-earnings ratio of 32.91, a PEG ratio of 1.39 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the business posted $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group’s payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on UNH shares. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Two analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.